Clinical Trials Browser

INDUSTRY × Leukemia, Myeloid × HhAntag691 × Clear all

NCT01880437 2015-12-15

A Study of Vismodegib in Patients With Relapsed/Refractory Acute Myelogenous Leukemia and Relapsed Refractory High-Risk Myelodysplastic Syndrome

Phase 2 Terminated

38 enrolled 11 charts

MyeloidOther hematologic neoplasm

Leukemia, Myeloid, Myelodysplastic Syndromes